Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide
Open Access
- 26 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12) , e52454
Abstract
Hypersensitivity diseases are associated with many severe human illnesses, including leprosy and tuberculosis. Emerging evidence suggests that the pathogenesis and pathological mechanisms of treating these diseases may be attributable to sphingolipid metabolism. High performance liquid chromatography-tandem mass spectrometry was employed to target and measure 43 core sphingolipids in the plasma, kidneys, livers and spleens of BALB/c mice from four experimental groups: control, delayed-type hypersensitivity (DTH) model, DTH+triptolide, and control+triptolide. Orthogonal partial least squares discriminant analysis (OPLS-DA) was used to identify potential biomarkers associated with variance between groups. Relationships between the identified biomarkers and disease markers were evaluated by Spearman correlation. As a treatment to hypersensitivity disease, triptolide significantly inhibit the ear swelling and recover the reduction of splenic index caused by DTH. The sphingolipidomic result revealed marked alterations in sphingolipid levels between groups that were associated with the effects of the disease and triptolide treatment. Based on this data, 23 potential biomarkers were identified by OPLS-DA, and seven of these biomarkers correlated markedly with the disease markers (p<0.05) by Spearman correlation. These data indicate that differences in sphingolipid levels in plasma and tissues are related to DTH and treatment with triptolide. Restoration of proper sphingolipid levels may attribute to the therapeutic effect of triptolide treatment. Furthermore, these findings demonstrate that targeted sphingolipidomic analysis followed by multivariate analysis presents a novel strategy for the identification of biomarkers in biological samples.Keywords
This publication has 44 references indexed in Scilit:
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of SphingolipidomicsChemical Reviews, 2011
- A targeted lipidomics approach to the study of eicosanoid release in synovial jointsArthritis Research & Therapy, 2011
- Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelinJournal of Allergy and Clinical Immunology, 2011
- Delayed drug hypersensitivity: models of T‐cell stimulationBritish Journal of Clinical Pharmacology, 2011
- Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathwayFitoterapia, 2011
- Sphingolipids: The Oil on the TRAFire That Promotes InflammationScience Signaling, 2010
- Sphingolipids in Multiple SclerosisNeuroMolecular Medicine, 2010
- Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and diseaseJournal of Lipid Research, 2009
- Triptolide Reduces Cystogenesis in a Model of ADPKDJournal of the American Society of Nephrology, 2008
- Effective therapy for nephritis in (NZB × NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook FArthritis & Rheumatism, 2008